SRF Limited ne Q3 FY26 ke liye ek mazboot 25% year-over-year EBIT growth report kiya hai, jiska mukhya karan chemical business mein 36% ki zabardast badhotri hai. Halanki, yeh headline growth underlying kamzoriyon ko chhupa rahi hai. Technical Textiles segment ka EBIT 24% gir gaya hai aur Performance Films division ne sirf 5% ki vriddhi darj ki hai. Chemical mein itni acchi performance aur Motilal Oswal dwara ₹3,660 ke price target ke saath BUY rating ke bawajood, market ki pratikriya savdhani bhari rahi hai. Investors segment mein bhedbhav aur broader industry headwinds ko tulna kar rahe hain.
Quarterly performance ka mukhya chalak fluorochemicals sub-segment raha, jise refrigerant ke liye domestic aur export markets mein higher volumes aur behtar pricing se fayda mila. Isne specialty chemicals ke kamzor performance ko offset kiya, jahan pricing pressure aur deferred orders ki samasyaein thi. Lekin, ek division ke positive results dusri jagah ki badi chunautiyon ko poori tarah se chhipa nahi paaye. Technical Textiles EBIT mein 24% ki tezi se hui YoY kami, demand ki lagatar samasyao aur tez pratiyogita ko darshati hai, jo analysts ke liye company ki overall diversification strategy par chinta ka vishay ban gayi hai.
### Valuation aur Market Headwinds
Earnings announce hone ke baad, SRF ke stock mein volatility dikhi hai, jo investor uncertainty ko darshata hai. Stock lagbhag 45x ke high trailing P/E ratio par trade kar raha hai, jo ek premium valuation hai aur chemical division se sustained high growth par nirbhar karta hai. Yeh valuation peers jaise Deepak Nitrite (41.15x) ki tulna mein kaafi zyada hai, lekin Navin Fluorine International (68.52x) se kam hai. Outlook ko aur jatil banate hue, global specialty chemical sector 2026 mein potential overcapacity aur subdued end-market demand ke karan chunautiyon ka samna kar sakta hai. Isi tarah, technical textiles sector bhi cautious global demand aur badhti operational pressures se nipat raha hai, jo batata hai ki 24% EBIT decline shayad short-term anomaly na ho. Analysts ne in pressures ko note kiya hai, kuch brokerages jaise Elara Capital ne specialty chemicals ke liye kamzor mahol ke karan FY26-28 ke liye EBITDA forecasts trim kiye hain.
### Peer Performance aur Future Outlook
SRF ka diversified model pariksha mein hai. Halanki chemical segment filhal ek mahatvapurna boost de raha hai, iske competitors bhi ek jatil mahol mein navigate kar rahe hain. Competitors jaise Pidilite Industries aur Gujarat Fluorochemicals bhi market cyclicality ka samna kar rahe hain. SRF ki growth trajectory maintain karne ki kshamata uske dusre pharma intermediate plant ke successful commissioning aur refrigerant pricing mein stability par heavily nirbhar hai. Management ne savdhani bhari optimism jatayi, lekin yeh acknowledge kiya ki FY26 ke liye pehle di gayi 20% sales growth guidance specialty chemicals ke liye shayad achievable na ho. Broader range ke analysts ka consensus savdhani bhara positive bana hua hai, lekin moderated hai, jiska average price target lagbhag ₹3,348 hai. Yeh potential upside suggest karta hai lekin underperforming segments aur mushkil macroeconomic backdrop se significant risks ko bhi acknowledge karta hai.